Congestive Heart Failure Treatment Devices Market

Congestive Heart Failure Treatment Devices Market Size by Product Type (Implantable Cardioverter Defibrillators, Ventricular Assist Devices, Pacemakers, and Cardiac Resynchronization Therapy), End-User (Ambulatory Surgical Centers, Hospitals, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-12869
  • Published Date: Aug, 2022
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global congestive heart failure treatment devices market is expected to reach USD 28.63 billion by 2030, at a CAGR of 6.93% from 2022 to 2030. The growing adoption of various treatments related to the heart drives the expansion of the congestive heart failure treatment devices market.

Market Overview:

A congestive heart failure is a machine that helps the heart function properly. It is an instrument utilized for the treatment of end-stage chronic heart failure. A congestive heart failure treatment gadget is also known as a mechanical circulatory help gadget. Additionally, there are different sorts of congestive heart failure treatment devices, such as cardiovascular resynchronization, ventricular help devices, pacemakers, and implantable cardioverter defibrillators. Congestive heart failure (CHF) is a chronic progressive condition impacting the heart muscle's pumping action. A ventricular aid is a device that supports siphoning the blood from the lower offices of the heart to the rest of the human body. Further, there are various types of ventricular assist devices like left congestive heart failure treatment devices (RVADs), right congestive heart failure treatment devices (LVADs), and others. Right congestive heart failure treatment devices pump blood to the pulmonary aorta from the right ventricle. Left congestive heart failure treatment devices are the most widely used ventricular assist devices, as most weak left ventricle muscles are shared among the affected patients.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers
  • The rising prevalence of cardiac disorders:

The increasing number of cardiovascular surgeries, trends in modern therapies, and technological improvements are driving the market growth. Further, the percutaneous circulatory support instruments help boost coronary perfusion, improve native cardiac output, reduce ventricular volume & filling pressures, and sustain vital organ perfusion. Thus, the benefits of congestive heart failure treatment devices contribute to the market's growth. Moreover, innovation of new medical devices, rise in healthcare facilities, and increased healthcare burden propel market growth.

Restraints:
  • High cost of congestive heart failure treatment devices:

The execution cost of these devices is extremely high due to the composition of different complex and progressive technologies. In addition, one of the significant factors hindering the deployment of congestive heart failure treatment devices is the high cost of operating and installing these instruments. There are a substantial number of people that suffer from cardiac diseases and disorders all over the globe. Congestive heart failure treatment devices are the most efficient and quick treatment for these disorders. Moreover, people all over the world are not able to leverage the full advantages of these appliances due to their high expenses.

Opportunities:
  • The growing number of efforts and initiatives being taken by the government and market vendors worldwide is the driving factor of market growth. Further, the governments in several nations have introduced several healthcare schemes, which a patient can leverage to treat several disorders& diseases. Moreover, the increasing deployment of cutting-edge technologies like ML & AI to improve cardiac care is also helping to propel the market growth during the forecast period.
Segmentation Analysis:

The global congestive heart failure treatment devices market has been segmented based on product type, end-user, and region.

  • The product type segment is divided into implantable cardioverter defibrillators, ventricular assist devices, pacemakers, and cardiac resynchronization therapy. The pacemakers segment led the market with a market share of 30.23% in 2021 due to the increased demand for congestive heart failure therapy devices for treating heart failure. Further, by 2030, the ventricular assist instruments segment will likely dominate the market due to the increased number of cardiac surgeries.
  • The end-user segment is divided into ambulatory surgical centers, hospitals, and others. The hospital's segment led the market with a market share of 41.12% in 2021 due to the increasing awareness of healthcare.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global congestive heart failure treatment devices market, with a 47.39% share of the market revenue in 2021.

  • The high prevalence of the aging population and end-stage heart failure is anticipated to contribute to the market for congestive heart failure treatment devices. Furthermore, varying policies followed regarding the adoption and funding in this region, and the increasing number of in-patients in hospitals related to congestive heart failure treatment also helped boost the market growth. Also, the rise in several cardiac surgeries and the healthcare sector's development promote market growth.
  • During the forecast period, the Asia Pacific region will record the highest growth due to the healthcare sector's development, and the progress fuelled by low-power electronics is helping to boost the market growth in this region. Additionally, the growing burden of patients with hypertension and increasing public & private spending for developing proper healthcare infrastructure also helps to drive the market growth. Further, the increasing focus of the key vendors to grow in emerging nations such as India and China is also boosting the market growth during the forecast period.

North America Region Congestive Heart Failure Treatment Devices Market Share in 2021 - 47.39%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global congestive heart failure treatment devices industry.

List of Key Market Players:

  • Abiomed Inc.
  • Biotronik SE and Co. KG
  • Lepu Medical
  • Abbot laboratories
  • Boston Scientific Corporation
  • Medtronic Plc
  • Berlin Heart GmbH
  • Microport Scientific Corporation
  • Jarvik Heart Inc
  • Osypka Medical GmbH

Key Target Audience:

  • Market Players
  • Investors
  • End-users
  • Government Authorities
  • Consulting And Research Firm

Report Description:

  • Global Congestive Heart Failure Treatment Devices Market, Industry Analysis, Trends, Analysis and Forecast, 2022 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2021 is considered as the base year of the report. 2019 and 2020 are considered as the historic years and 2022 to 2030 are the forecast years. The global congestive heart failure treatment devices market is based on revenue (USD Billion). The report incorporates the market study based on revenue. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global congestive heart failure treatment devices market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts across the globe. The research report also delivers an outline of the attractiveness of congestive heart failure treatment devices based on product type, end-user and regions which are deduced and formulated based on their growth rate (CAGR), market size, and attractiveness by analyzing the present and prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global congestive heart failure treatment devices market. This offers vital and in-depth insights to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global congestive heart failure treatment devices market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario.
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors.
  • Potential growth prospects along with the penetration rate analysis of the product (market related i.e., global congestive heart failure treatment devices market) is covered to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the congestive heart failure treatment devices market was valued at USD 15.67 billion in 2021 to USD 28.63 billion by 2030.

Global congestive heart failure treatment devices market is growing at a CAGR of 6.93% during the forecast period 2022-2030.

The global congestive heart failure treatment devices market has been segmented based on product type, end-user, and regions. The pacemakers segment led product type segment in 2021. The hospitals segment led the end-user segment in 2021.

North America region emerged as the largest market for the congestive heart failure treatment devices.

The market's growth will be influenced by the growing adoption of various treatments related to the heart.

The high cost of congestive heart failure treatment devices could hamper the market growth.

The increasing number of initiatives by government and industry players will provide huge opportunities to the market.

Key players are Abiomed Inc., Biotronik SE and Co. KG, Lepu Medical, Abbot laboratories, Boston Scientific Corporation, Medtronic Plc, Berlin Heart GmbH, Microport Scientific Corporation, Jarvik Heart Inc, Osypka Medical GmbH, among others.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product Type
          4.3.2. Market Attractiveness Analysis By End-User
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Market Evaluation
    5.3. Drivers
          5.3.1. The growing adoption of various treatments related to the heart
          5.3.2. The rising healthcare burden
          5.3.3. The increased healthcare facilities
          5.3.4. The technological advancement in congestive heart failure treatment devices
    5.4. Restraints
          5.4.1. The high cost of congestive heart failure treatment devices
    5.5. Opportunities
          5.5.1. The increasing number of initiatives by government and industry players

6. Global Congestive Heart Failure Treatment Devices Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Implantable Cardioverter Defibrillators
    6.3. Ventricular Assist Devices
    6.4. Pacemakers
    6.5. Cardiac Resynchronization Therapy

7. Global Congestive Heart Failure Treatment Devices Market Analysis and Forecast, By End-User
    7.1. Segment Overview
    7.2. Ambulatory Surgical Centers
    7.3. Hospitals
    7.4. Others

8. Global Congestive Heart Failure Treatment Devices Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Congestive Heart Failure Treatment Devices Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Congestive Heart Failure Treatment Devices Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Abiomed Inc.
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Biotronik SE and Co. KG
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Lepu Medical
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Abbot laboratories
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Boston Scientific Corporation
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Medtronic Plc
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Berlin Heart GmbH
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Microport Scientific Corporation
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Jarvik Heart Inc
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Osypka Medical GmbH
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis

List of Table

1. Global Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

2. Global Implantable Cardioverter Defibrillators, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion) 

3. Global Ventricular Assist Devices, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

4. Global Pacemakers, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

5. Global Cardiac Resynchronization Therapy, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

6. Global Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

7. Global Ambulatory Surgical Centers, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

8. Global Hospitals, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

9. Global Others, Congestive Heart Failure Treatment Devices Market, By Region, 2019-2030 (USD Billion)

10. North America Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

11. North America Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

12. U.S. Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

13. U.S. Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

14. Canada Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

15. Canada Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

16. Mexico Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

17. Mexico Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

18. Europe Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

19. Europe Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

20. Germany Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

21. Germany Congestive Heart Failure Treatment Devices Market, By End-User, 2019-2030 (USD Billion)

22. France Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

23. France Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

24. U.K. Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

25. U.K. Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

26. Italy Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

27. Italy Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

28. Spain Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

29. Spain Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

30. Asia Pacific Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

31. Asia Pacific Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

32. Japan Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

33. Japan Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

34. China Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

35. China Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

36. India Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

37. India Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

38. South America Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

39. South America Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

40. Brazil Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

41. Brazil Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

42. Middle East and Africa Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

43. Middle East and Africa Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

44. UAE Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

45. UAE Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

46. South Africa Congestive Heart Failure Treatment Devices Market, By Product Type, 2019-2030 (USD Billion)

47. South Africa Congestive Heart Failure Treatment Devices Market, By End-User 2019-2030 (USD Billion)

List of Figures 

1. Global Congestive Heart Failure Treatment Devices Market Segmentation

2. Global Congestive Heart Failure Treatment Devices Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Congestive Heart Failure Treatment Devices Market Attractiveness Analysis By Product Type

9. Global Congestive Heart Failure Treatment Devices Market Attractiveness Analysis By End-User 

10. Global Congestive Heart Failure Treatment Devices Market Attractiveness Analysis By Region

11. Global Congestive Heart Failure Treatment Devices Market: Dynamics

12. Global Congestive Heart Failure Treatment Devices Market Share By Product Type (2022 & 2030)

13. Global Congestive Heart Failure Treatment Devices Market Share By End-User (2022 & 2030)

14. Global Congestive Heart Failure Treatment Devices Market Share By Regions (2022 & 2030)

15. Global Congestive Heart Failure Treatment Devices Market Share By Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global congestive heart failure treatment devices based on below mentioned segments:

Global Congestive Heart Failure Treatment Devices Market by Product Type:

  • Implantable Cardioverter Defibrillators
  • Ventricular Assist Devices
  • Pacemakers
  • Cardiac Resynchronization Therapy

Global Congestive Heart Failure Treatment Devices Market by End-User:

  • Ambulatory Surgical Centers
  • Hospitals
  • Others

Global Congestive Heart Failure Treatment Devices by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date